EPISODE · Dec 23, 2024 · 44 MIN
Semaglutide vs. Tirzepitide: Which Obesity Drug Could Be Your Game Changer Part 2
from The Plus SideZ: A GLP-1 Guide to Metabolic Health · host Kim Carlos
Resources for the Community:____________________________________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55If You are having issues accessing Paid Subscriber content please send an email to [email protected] and a member of Buzzsprout's technical team will help you access the content.____________________________________________________________________________________________Part 2This episode delves into the intricate relationship between insulin resistance, polycystic ovarian syndrome (PCOS), and obesity. We explore how these conditions often intertwine, leading to a cyclical pattern that can be challenging to break.We discuss the fascinating study of adipose tissue's remarkable ability to remember past weight gain, even after significant weight loss. This phenomenon sheds light on the persistent challenges faced by individuals who have lost weight and are striving to maintain their progress.We also delve into the critical role of basal metabolic rate (BMR) and caloric consumption in weight management. Understanding these factors can empower individuals to make informed choices about their diet and exercise routines.Finally, we compare and contrast two groundbreaking medications, semaglutide and tirzepitide. Both drugs have shown remarkable efficacy in treating obesity, but there are key differences in their mechanisms of action and potential side effects. We explore the latest research to determine which medication may be the best fit for different individuals.____________________________________________________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 for $ OFF____________________________________________________________________________________________Join this channel to get access to perks: / @theplussidez______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy Send us Fan Mail!Support the showKim Carlos, Executive Producer TikTokInstagram Kat Carter, Producer TikTokInstagram
Embed this episode
What this episode covers
Resources for the Community: ____________________________________________________________________________________________ https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55 If You are having issues accessing Paid Subscriber content please send an email to [email protected] and a member of Buzzsprout's technic...
NOW PLAYING
Semaglutide vs. Tirzepitide: Which Obesity Drug Could Be Your Game Changer Part 2
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.